To determine the incidence of angioedema associated with ACE inhibitors versus placebo in the treatment of primary hypertension.
This is a protocol.
To determine the incidence of angioedema associated with ACE inhibitors versus placebo in the treatment of primary hypertension.
This is a protocol.